U.S. Travelers Warned About Counterfeit Pills Containing Fentanyl in Mexico Pharmacies
MONDAY, March 20, 2023 (HealthDay News) — Travelers should use caution when buying medications in Mexico, according to the U.S. State Department.The warning was issued in response to concerns about counterfeit pills containing fentanyl being sold at …
Learn MoreOne-Quarter of Older Advanced Cancer Patients Taking Eight or More Drugs
MONDAY, March 20, 2023 (HealthDay News) — Among older adults with advanced cancer, polypharmacy and potential drug-drug interactions are associated with an increased risk for adverse treatment outcomes, according to a study published in the April 1 i…
Learn MoreFDA Advisers Back Full Approval of Paxlovid
FRIDAY, March 17, 2023 (HealthDay News) — Paxlovid, a medication that has helped millions of high-risk COVID-19 patients avoid hospitalization and death since late 2021, moved one step closer to getting full approval from the U.S. Food and Drug Admin…
Learn MoreLebrikizumab Effective for Adults, Teens With Atopic Dermatitis
THURSDAY, March 16, 2023 (HealthDay News) — For adults and adolescents with moderate-to-severe atopic dermatitis, 16 weeks of lebrikizumab is effective, according to a study published online March 15 in the New England Journal of Medicine.Jonathan I….
Learn MoreClozapine, ECT, Lithium May Prevent Suicide in Male Teens With Severe Mental Illness
THURSDAY, March 16, 2023 (HealthDay News) — For male adolescents with severe mental illness, suicide prevention may benefit from clozapine, electroconvulsive therapy (ECT), and lithium (CEL) treatment, according to a study published online March 14 i…
Learn MorePEPFAR Has Scaled Up HIV ART to About 20 Million Persons Since 2004
WEDNESDAY, March 15, 2023 (HealthDay News) — The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has scaled up HIV antiretroviral therapy (ART) to about 20 million persons with HIV infection in 54 countries since 2004, according to research…
Learn MoreLa FDA aprueba un nuevo aerosol nasal para las migrañas
LUNES, 13 de marzo de 2023 (HealthDay News) — Las personas que sufren migrañas pronto contarán con una nueva opción de tratamiento que funciona con una mayor rapidez, y que quizá sea más segura para las personas en riesgo de ataque cardiaco y acciden…
Learn MoreACC: Coordinated Intervention Increases Rx for Evidence-Based T2DM Therapies
TUESDAY, March 14, 2023 (HealthDay News) — A coordinated, multifaceted intervention increases prescription of three groups of evidence-based therapies in adults with type 2 diabetes and atherosclerotic cardiovascular disease (CVD), according to a stu…
Learn MoreFDA Approves First Treatment for Rett Syndrome
TUESDAY, March 14, 2023 (HealthDay News) – The U.S. Food and Drug Administration has approved Daybue (trofinetide) for the treatment of Rett syndrome in adult and pediatric patients aged 2 years and older.Approval was based on results from the phase 3…
Learn MorePara los adultos mayores que toman antidepresivos, añadir un fármaco quizá sea mejor que cambiarlo
VIERNES, 10 de marzo de 2023 (HealthDay News) — Muchos adultos mayores con depresión no responden al primer antidepresivo, de forma que los médicos lo cambian a otro para ver eso si funciona.Ahora, una nueva investigación sugiere que la mejor estrate…
Learn More